Video

Lisa Backus: Examining Efficacy of Hepatitis Medications

As medications for hepatitis C become more widely used, studies are being done to see how effective these treatments are when used in combination.

As medications for hepatitis C become more widely used, studies are being done to see how effective these treatments are when used in combination.

Speaking at the annual Digestive Disease Week (DDW) 2016 meeting in San Diego, California, Lisa Backus, MD, PhD , from the US Department of Veterans Affairs discussed the results of a recent study looking at some of the more popular medications available on the market. Backus said the study was important because they wanted to see whether the treatments were as effective in real-world practice as they were during clinical trials in the approval process.

Also on MD Magazine >>> More news from Digestive Disease Week 2016

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.